In a case that could shape the future of psychedelic medicine, a palliative care physician is challenging a DEA decision that bars him from prescribing psilocybin to late-stage cancer patients.
In a case that could shape the future of psychedelic medicine, a palliative care physician is challenging a DEA decision that bars him from prescribing psilocybin to late-stage cancer patients.